Regulatory information – 1.7% increase of fees from 1 April 2018

March 28, 2018 – General, non-pharmacovigilance fees payable to the European Medicines Agency (EMA) by applicants and marketing-authorisation holders are increasing by 1.7% on 1 April 2018. Full details of the new fee levels are available in Commission Regulation (EU) No 2018/471 amending Council Regulation (EC) No 297/95, its implementing rules and the corresponding explanatory note on fees, published on 28 March. These documents include the new fees … (leggi tutto)